Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.
Eur J Pharmacol
; 935: 175321, 2022 Nov 15.
Article
in En
| MEDLINE
| ID: mdl-36228744
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
/
Plantas_medicinales
Main subject:
Prodrugs
/
Curcumin
Language:
En
Journal:
Eur J Pharmacol
Year:
2022
Type:
Article
Affiliation country:
Japan